Cooling Agents in E-Cigarettes Linked to Cardiovascular Effects in Mouse Study
Menthol and synthetic cooling agents (WS-3 and WS-23) commonly used in flavored e-cigarettes have been associated with cardiovascular effects in a recent mouse study. These compounds activate the TRPM8 cold receptor, creating a cooling sensation without changing the actual temperature of the aerosol. Cell studies also indicate potential damage to blood vessel lining. Researchers caution that the findings have not been confirmed in humans.
Mechanism of Action
- Cooling agents such as menthol and the synthetic compounds WS-3 and WS-23 bind to TRPM8 receptors in the body.
- This activation causes a perception of coolness without a corresponding drop in the physical temperature of the e-cigarette aerosol.
- The effect may encourage deeper inhalation and more frequent use among vapers.
Key Research Findings
Animal Study- A study on mice found that exposure to menthol-containing e-cigarette aerosols led to increased heart rate, elevated blood pressure, and an increased occurrence of ventricular premature beats.
- The study also recorded elevated levels of epinephrine.
- Some changes in heart rhythm persisted for several weeks after the exposure ended.
- The direct applicability of these results to humans requires verification through larger-scale human studies.
- Laboratory research indicates that certain flavoring chemicals can damage endothelial cells, which line the inside of blood vessels.
- This damage was associated with increased inflammation and cell death, even in the absence of nicotine.
- Damage to the blood vessel lining is a recognized early indicator of cardiovascular disease.
Regulatory and Safety Context
A substance determined to be safe for ingestion may not be safe for inhalation, as the lungs provide a more direct route for absorption into the bloodstream.
- Synthetic cooling agents are increasingly used in fruit, candy, and beverage-flavored vape products to provide a strong cooling sensation without a mint taste.
- New e-liquid formulations can enter the market before comprehensive studies on their health effects have been completed.
- Researchers note that these cooling compounds are not biologically inert, contrary to some earlier assumptions.